Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07485608 · ClinicalTrials.gov registry record · NA
Reducing Lead Dust Exposure in Older Housing
A NA study of Exposure to Toxic Dust and Elevated Blood Lead Levels, sponsored by Michigan State University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07485608: Recruiting NA study of Exposure to Toxic Dust and Elevated Blood Lead Levels, sponsored by Michigan State University.
NCT07485608 is a NA study of Exposure to Toxic Dust and Elevated Blood Lead Levels that is actively recruiting participants, run by Michigan State University. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07485608, a NA study of Exposure to Toxic Dust and Elevated Blood Lead Levels, is actively recruiting participants, sponsored by Michigan State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to assess the effectiveness of portable air filtration (PAF) for mitigating lead dust exposures and reducing childhood blood lead levels in older housing.
Primary Outcome
change in blood lead level (in ug/dL).
Conditions Studied
Interventions
- OTHER portable air filtration systems
Study Locations (1)
Michigan
- Michigan State University - East Lansing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
What NCT07485608 shows while recruiting
NCT07485608 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Exposure to Toxic Dust appearing as the primary indexed condition, and to 1 intervention - of which portable air filtration systems is the first listed.
NCT07485608 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT07485608 about?
NCT07485608 is a clinical study titled "Reducing Lead Dust Exposure in Older Housing". The objective of this study is to assess the effectiveness of portable air filtration (PAF) for mitigating lead dust exposures and reducing childhood blood lead levels in older housing.
What is the current status of trial NCT07485608?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2022-12-01. Estimated completion is 2026-11-30.
What conditions does trial NCT07485608 study?
This clinical trial studies the following conditions: Exposure to Toxic Dust, Elevated Blood Lead Levels.
What interventions are being tested in trial NCT07485608?
The interventions under investigation include: portable air filtration systems (OTHER).
Who is sponsoring clinical trial NCT07485608?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07485608 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07485608's enrollment target sits among peer trials
40 1448th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI